Company / AR per Share
10x Genomics, Inc. AR per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.38
FY2025
5-year range
$0.38 / $1.00
FY2021-FY2025
Trend
-47.9%
vs FY2024
Sector context
#128 of 141
Health Care
What the data says
Among 141 Health Care companies, 10x Genomics, Inc. is in the bottom 9% for ar per share. AR per Share has fluctuated over the past 8 years, ranging from $0.38 in FY2025 to $2.29 in FY2019.
Based on SEC 10-K filings.
0.38 in FY2025 with a 5-year CAGR of -6.3%.
Declined from $1.00 to $0.38 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -25.4%
- 5-Year CAGR
- -6.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 141This company $0.38 Sector average $11.78
▼
-96.7% below sector average
Key checks
Key Insights
- In FY2025, ar per share decreased 47.9% year-over-year.
- Ranks #128 out of 141 companies in the Health Care sector.
- Peak ar per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.38 | -47.9% |
| FY2024 | $0.74 | -26.0% |
| FY2023 | $1.00 | +7.6% |
| FY2022 | $0.93 | +17.9% |
| FY2021 | $0.79 | +47.7% |
| FY2020 | $0.53 | -76.8% |
| FY2019 | $2.29 | +9.4% |
| FY2018 | $2.10 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026